Perspective Therapeutics, Inc. — Director's Dealing 2016

Jun 23, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2016-06-14

Reporting Person: Krachon Michael (VP of Sales & Marketing)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.83	2026-03-07	Common Stock (125000)		Direct

Footnotes

F1: (1) 1/3 vest on March 7, 2017, 1/3 vest on March 7, 2018, and 1/3 vest on March 7, 2019